These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31569155)

  • 41. The Role of Epigenetics in the Latent Effects of Early Life Exposure to Obesogenic Endocrine Disrupting Chemicals.
    Stel J; Legler J
    Endocrinology; 2015 Oct; 156(10):3466-72. PubMed ID: 26241072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Health behaviors related to endocrine-disrupting chemicals and the associated factors of adolescent Korean girls.
    Park S; Chung C
    Women Health; 2018 Sep; 58(8):915-929. PubMed ID: 28805534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exposure to indoor endocrine-disrupting chemicals and childhood asthma and obesity.
    Paciência I; Cavaleiro Rufo J; Silva D; Martins C; Mendes F; Farraia M; Delgado L; de Oliveira Fernandes E; Padrão P; Moreira P; Severo M; Barros H; Moreira A
    Allergy; 2019 Jul; 74(7):1277-1291. PubMed ID: 30740706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of maternal exposure to endocrine disrupting chemicals on fetal and neonatal development: A review on the major concerns.
    Mallozzi M; Bordi G; Garo C; Caserta D
    Birth Defects Res C Embryo Today; 2016 Sep; 108(3):224-242. PubMed ID: 27653964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of perinatal environmental health education intervention on exposure to endocrine disruptors during pregnancy-PREVED study: study protocol for a randomized controlled trial.
    Ouazzani HE; Rouillon S; Venisse N; Sifer-Rivière L; Dupuis A; Cambien G; Ayraud-Thevenot S; Gourgues AS; Pierre-Eugène P; Pierre F; Rabouan S; ; Migeot V; Albouy-Llaty M
    Trials; 2021 Dec; 22(1):876. PubMed ID: 34863252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endocrine-disrupting chemicals and uterine fibroids.
    Katz TA; Yang Q; Treviño LS; Walker CL; Al-Hendy A
    Fertil Steril; 2016 Sep; 106(4):967-77. PubMed ID: 27553264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sex-specific enhanced behavioral toxicity induced by maternal exposure to a mixture of low dose endocrine-disrupting chemicals.
    Sobolewski M; Conrad K; Allen JL; Weston H; Martin K; Lawrence BP; Cory-Slechta DA
    Neurotoxicology; 2014 Dec; 45():121-30. PubMed ID: 25454719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Environmental influences on female fecundity and fertility.
    Buck Louis GM; Lynch CD; Cooney MA
    Semin Reprod Med; 2006 Jul; 24(3):147-55. PubMed ID: 16804813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary phthalate metabolite concentrations in relation to history of infertility and use of assisted reproductive technology.
    Alur S; Wang H; Hoeger K; Swan SH; Sathyanarayana S; Redmon BJ; Nguyen R; Barrett ES
    Fertil Steril; 2015 Nov; 104(5):1227-35. PubMed ID: 26275821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dimorphic placental stress: A repercussion of interaction between endocrine disrupting chemicals (EDCs) and fetal sex.
    Sood S; Shekhar S; Santosh W
    Med Hypotheses; 2017 Feb; 99():73-75. PubMed ID: 28110704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis.
    Bonde JP; Flachs EM; Rimborg S; Glazer CH; Giwercman A; Ramlau-Hansen CH; Hougaard KS; Høyer BB; Hærvig KK; Petersen SB; Rylander L; Specht IO; Toft G; Bräuner EV
    Hum Reprod Update; 2016 Dec; 23(1):104-125. PubMed ID: 27655588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroendocrine and behavioral effects of embryonic exposure to endocrine disrupting chemicals in birds.
    Ottinger MA; Lavoie E; Thompson N; Barton A; Whitehouse K; Barton M; Abdelnabi M; Quinn M; Panzica G; Viglietti-Panzica C
    Brain Res Rev; 2008 Mar; 57(2):376-85. PubMed ID: 18006066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Male pubertal development: are endocrine-disrupting compounds shifting the norms?
    Zawatski W; Lee MM
    J Endocrinol; 2013; 218(2):R1-12. PubMed ID: 23709001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endocrine-disrupting chemicals, risk of type 2 diabetes, and diabetes-related metabolic traits: A systematic review and meta-analysis.
    Song Y; Chou EL; Baecker A; You NC; Song Y; Sun Q; Liu S
    J Diabetes; 2016 Jul; 8(4):516-32. PubMed ID: 26119400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of endocrine disrupting chemicals in pigs.
    Yang C; Song G; Lim W
    Environ Pollut; 2020 Aug; 263(Pt B):114505. PubMed ID: 32268228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Firm human evidence on harms of endocrine-disrupting chemicals was unlikely to be obtainable for methodological reasons.
    Lee DH; Jacobs DR
    J Clin Epidemiol; 2019 Mar; 107():107-115. PubMed ID: 30543909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.
    Hauser R; Skakkebaek NE; Hass U; Toppari J; Juul A; Andersson AM; Kortenkamp A; Heindel JJ; Trasande L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1267-77. PubMed ID: 25742517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Developmental Exposure to Environmental Chemicals and Metabolic Changes in Children.
    Russ K; Howard S
    Curr Probl Pediatr Adolesc Health Care; 2016 Aug; 46(8):255-85. PubMed ID: 27401018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methodological issues in human studies of endocrine disrupting chemicals.
    Lee DH; Jacobs DR
    Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.